1. Home
  2. ARAY vs MITT Comparison

ARAY vs MITT Comparison

Compare ARAY & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARAY
  • MITT
  • Stock Information
  • Founded
  • ARAY 1990
  • MITT 2011
  • Country
  • ARAY United States
  • MITT United States
  • Employees
  • ARAY N/A
  • MITT N/A
  • Industry
  • ARAY Medical/Dental Instruments
  • MITT Real Estate Investment Trusts
  • Sector
  • ARAY Health Care
  • MITT Real Estate
  • Exchange
  • ARAY Nasdaq
  • MITT Nasdaq
  • Market Cap
  • ARAY 229.3M
  • MITT 191.8M
  • IPO Year
  • ARAY 2007
  • MITT 2011
  • Fundamental
  • Price
  • ARAY $2.11
  • MITT $7.42
  • Analyst Decision
  • ARAY Strong Buy
  • MITT Buy
  • Analyst Count
  • ARAY 1
  • MITT 5
  • Target Price
  • ARAY $9.00
  • MITT $8.30
  • AVG Volume (30 Days)
  • ARAY 883.1K
  • MITT 188.6K
  • Earning Date
  • ARAY 02-05-2025
  • MITT 03-04-2025
  • Dividend Yield
  • ARAY N/A
  • MITT 10.24%
  • EPS Growth
  • ARAY N/A
  • MITT 269.43
  • EPS
  • ARAY N/A
  • MITT 2.09
  • Revenue
  • ARAY $453,140,000.00
  • MITT $80,741,000.00
  • Revenue This Year
  • ARAY $6.97
  • MITT N/A
  • Revenue Next Year
  • ARAY $5.02
  • MITT $20.57
  • P/E Ratio
  • ARAY N/A
  • MITT $3.55
  • Revenue Growth
  • ARAY 1.26
  • MITT 17.98
  • 52 Week Low
  • ARAY $1.40
  • MITT $5.44
  • 52 Week High
  • ARAY $2.95
  • MITT $7.95
  • Technical
  • Relative Strength Index (RSI)
  • ARAY 43.05
  • MITT 72.55
  • Support Level
  • ARAY $2.15
  • MITT $6.95
  • Resistance Level
  • ARAY $2.32
  • MITT $7.36
  • Average True Range (ATR)
  • ARAY 0.16
  • MITT 0.11
  • MACD
  • ARAY -0.04
  • MITT 0.05
  • Stochastic Oscillator
  • ARAY 4.55
  • MITT 91.02

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About MITT AG Mortgage Investment Trust Inc.

AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long-term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government sponsored enterprise.

Share on Social Networks: